Barinthus Biotherapeutics plc
- BRNS
- NASDAQ
- Biotechnology
- Immunotherapy (SNAP-TI Platform)
- Autoimmune/Inflammatory Disease
$0.74
Today −2.49%Quote Sep 8, 2026, 08:00 PM UTC
+24.68%over the last month
Max drawdown −6.6%From 1-month high −3.3%3 months +5.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$30.2M
Quote Sep 8
Next earnings
Nov 6
Expected, not confirmed
Analyst target
$3.00
+305.4% from here
Floor
$0.74
0.0% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BRNSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
14